Action potential recordings and analysis in human ventricular trabeculae for assessment of pro-arrhythmic risk

被引：0
|
作者：
Qu, Yusheng [1 ]
Page, Guy [2 ]
Abi-Gerges, Najah [2 ]
Miller, Paul [2 ]
Ghetti, Andre [2 ]
Vargas, Hugo M. [1 ]
机构：
[1] Amgen Inc, Integrated Discovery & Safety Pharmacol, Thousand Oaks, CA 91320 USA
[2] AnaBios Corp, San Diego, CA USA
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2018年 / 93卷
关键词：
D O I：
10.1016/j.vascn.2018.01.506
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
138
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [31] Pro-arrhythmic Effects of Increased Late Sodium Current in Failing Human Heart
    Bai, Jieyun
    Wang, Kuanquan
    Bai, Xiangyun
    Yuan, Yongfeng
    Zhang, Henggui
    2014 COMPUTING IN CARDIOLOGY CONFERENCE (CINC), VOL 41, 2014, 41 : 857 - 860
  • [32] A COMPARISON OF THE PRO-ARRHYTHMIC EFFECTS OF INTRAVENOUS PROCAINAMIDE AND ORAL FLECAINIDE AS ASSESSED BY PROGRAMMED VENTRICULAR STIMULATION
    SHANNON, JA
    MCLARAN, CJ
    STAFFORD, WJ
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1988, 18 (03): : 381 - 381
  • [33] Computational Probabilistic Quantification of Pro-arrhythmic Risk from Scar and Left-to-Right Heterogeneity in the Human Ventricles
    Wallman, Mikael
    Bueno-Orovio, Alfonso
    Rodriguez, Blanca
    2013 COMPUTING IN CARDIOLOGY CONFERENCE (CINC), 2013, 40 : 711 - 714
  • [34] Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes
    Song, YJ
    Shryock, JC
    Wu, L
    Belardinelli, L
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 (02) : 192 - 199
  • [35] Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic Risk
    Davies, Mark R.
    Martinec, Michael
    Walls, Robert
    Schwarz, Roman
    Mirams, Gary R.
    Wang, Ken
    Steiner, Guido
    Surinach, Andy
    Flores, Carlos
    Lave, Thierry
    Singer, Thomas
    Polonchuk, Liudmila
    CELL REPORTS MEDICINE, 2020, 1 (05)
  • [36] ASSESSING PRO-ARRHYTHMIC RISK DUE TO QTC PROLONGATION - EXPERIENCE WITH TARGETED THERAPIES IN ONCOLOGY
    Budha, N.
    Saif, S.
    Dresser, M.
    Sahasranaman, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S19 - S19
  • [37] Arrhythmogenic cardiomyopathy: pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy
    van der Voorn, Stephanie M.
    te Riele, Anneline S. J. M.
    Basso, Cristina
    Calkins, Hugh
    Remme, Carol Ann
    van Veen, Toon A. B.
    CARDIOVASCULAR RESEARCH, 2020, 116 (09) : 1571 - 1584
  • [38] Human Purkinje in silico model enables mechanistic investigations into automaticity and pro-arrhythmic abnormalities
    Trovato, Cristian
    Passini, Elisa
    Nagy, Norbert
    Varro, Andras
    Abi-Gerges, Najah
    Severi, Stefano
    Rodriguez, Blanca
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 142 : 24 - 38
  • [39] Ventricular pro-arrhythmic effect of chronic atrial fibrillation in patients with left ventricular dysfunction and implantable cardioverter-defibrillator
    Almeida, S.
    Gomes, R.
    Rocha, S.
    Silva, J.
    Cavaco, D.
    Santos, K.
    Morgado, F.
    Adragao, P.
    Silva, A.
    EUROPEAN HEART JOURNAL, 2009, 30 : 416 - 416
  • [40] Pro-arrhythmic role of adrenergic spatial densities in the human atria: An in-silico study
    Magtibay, Karl
    Masse, Stephane
    Nanthakumar, Kumaraswamy
    Umapathy, Karthikeyan
    PLOS ONE, 2023, 18 (08):
12345